Science Current Events | Science News | Brightsurf.com
 

Prostate Cancer Treatment Current Events | Prostate Cancer Treatment News

Page 1 of 127 | 3170 Results
Previous0102030405060708091011   Next   
Sort By: Page Views | Date
Low-risk prostate cancer patients face overtreatment
Many low-risk prostate cancer patients are being overtreated and might fare better if doctors monitored the cancer until treatment was necessary.   view more (2006-08-16)

MR imaging helps predict recurrence in prostate cancer patients
MR images taken of prostate cancer patients prior to treatment that show that the cancer has spread outside the prostate gland capsule help predict whether the cancer will return.   view more (2007-05-07)

Prostate specific antigen: A review of PSA use in screening for prostate cancer
Screening for prostate cancer using prostate specific antigen (PSA) testing continues to be problematic. Even though it is unproven whether population-wide screening with PSA can reduce death, illness or disability from prostate cancer, testing has become common in North America.   view more (2007-06-19)

PROSTATE CANCER SERIES (p 859)
A four-week series about prostate cancer-the third most common cancer in men worldwide, and the leading male cancer in Europe and North America-begins in this week's issue of THE LANCET. The first article, by Henrik Grönberg of Umea University, Sweden, assesses the epidemiology of prostate... view more (2003-03-05)

University of Kent Study Aims To Improve Information And Support Needs For Older Men With Prostate Cancer
The Centre for Health Services Studies (CHSS) at the University of Kent is currently engaged in an exploratory study of the information and support needs for men aged 75+ with prostate cancer.   view more (2004-11-03)

Men with prostate cancer want screening despite doubts over effectiveness of treatment
Most men with prostate cancer strongly advocate routine testing for prostate specific antigen (PSA), despite evidence that aggressive screening and treatment does not reduce deaths, according to two studies in this week's BMJ. In the first study, researchers at the University of Oxford interviewed... view more (2002-10-02)

Annual prostate cancer screening test appears to save lives
Men who have a yearly blood test to examine their prostate specific antigen levels are nearly three times less likely to die from prostate cancer than those who don't have annual screenings.   view more (2005-10-20)

New prostate cancer marker helps identify men whose cancer is likely to spread
Prostate cancer researchers at Sydney's Garvan Institute, supported by the Cancer Institute NSW, have found a new marker for identifying aggressive prostate cancers.   view more (2006-10-04)

Radiation seeds effectively cure prostate cancer in young men
Radiation seed implants (brachytherapy) are just as effective at curing prostate cancer in younger men (aged 60 and younger) as they are in older men.   view more (2007-10-30)

US prostate cancer deaths down one third in men aged 50-74: Europe following?
Copenhagen, Denmark: New findings presented today (Tuesday 23 September) at ECCO 12 - The European Cancer Conference, show that US prostate cancer mortality rates, which had been increasing slowly during the 1970s and 1980s, suddenly started to fall rapidly during the 1990s.   view more (2003-09-21)

MRI findings help forecast prostate cancer prognosis
Magnetic resonance imaging (MRI) findings in patients about to undergo radiation therapy for prostate cancer can help predict the likelihood that the cancer will return and spread post-treatment, according to a new study published in the April issue of the journal Radiology.   view more (2008-03-25)

Hormone therapy before radiation seed implants for prostate cancer
Men over 70 years of age with early-stage prostate cancer have 20 percent higher mortality if they are treated first with hormone therapy before being treated with radiation seed implants (brachytherapy), compared to men who are treated with brachytherapy alone.   view more (2008-09-23)

Prostate cancer patients see high survival rates with seed implants
More than ninety percent of men who receive appropriate radiation dose levels with permanent radiation seed implants to treat their prostate cancer are cured of their cancer eight years after diagnosis.   view more (2007-02-01)

PSA velocity's clinical usefulness remains unclear
Some studies have suggested that the rate of change of prostate-specific antigen (PSA) levels may correspond with prostate cancer survival. But this does not necessarily mean that PSA velocity will be valuable as a prostate cancer screening tool.   view more (2007-10-10)

Speed of PSA rise helps predict survival for prostate cancer patients
The clinical outcome for prostate cancer patients who have been treated with hormone therapy and radiation therapy can usually be determined by how rapidly their prostate specific antigen level rises following treatment.   view more (2005-10-03)

Largest PSA bounce study eases worry of prostate cancer returning
Prostate cancer patients who have a temporary rise in their prostate specific antigen (PSA) levels after radiation therapy-called a PSA bounce-are not at an increased risk of their cancer coming back any more than those who don't have a temporary rise.   view more (2006-11-09)

Early warning: PSA testing can predict advanced prostate cancer
Researchers who showed that a single prostate specific antigen (PSA) test at age 50 or under could predict the presence of prostate cancer up to 25 years later, (regardless of clinical significance) have now found that a single PSA can be used to predict advanced prostate cancer.   view more (2008-02-15)

PSA predicts treatment success in advanced prostate cancer
A test used to detect prostate cancer can also help doctors know when treatment is working.   view more (2006-08-24)

PSA is poor predictor of lethal prostate cancer
The amount of prostate-specific antigen (PSA) in a man's bloodstream at the time of his prostate cancer diagnosis or its rate of change over the course of the disease does not adequately predict lethal prostate cancer.   view more (2007-04-04)

Drug reverses bone loss in men with prostate cancer during the first year of treatment
A common type of treatment used to protect bone density in menopausal women is also an effective therapy for advanced prostate cancer patients during the first year of hormone therapy.   view more (2006-02-27)

OHSU Cancer Institute researchers find novel chemo drug helps treat prostate cancer
Men with a certain type of prostate cancer have been shown to respond to a new chemotherapy drug, Sagopilone, plus prednisone in an international trial led by Oregon Health & Science University Cancer Institute researchers.   view more (2008-06-02)

Prostate cancer spurs new nerves
Prostate cancer - and perhaps other cancers - promotes the growth of new nerves and the branching axons that carry their messages, a finding associated with more aggressive tumors, said researchers from Baylor College of Medicine in the first report of the phenomenon that appears today in the... view more (2008-12-01)

DEFINITIVE STUDY OF CANCER WAITING TIMES SUGGESTS MAJOR CHALLENGE FOR NHS
The paper, by Spurgeon, Barwell and Kerr at the University of Birmingham, will provide valuable baseline data which can be used to set targets for improvement in cancer services. The authors invited all English acute hospital trusts to submit data on new patients diagnosed with cancer during... view more (2000-03-13)

Jefferson scientists find protein potential drug target for treatment-resistant prostate cancer
Scientists at Jefferson's Kimmel Cancer Center in Philadelphia have found that a signaling protein that is key to prostate cancer cell growth is turned on in nearly all recurrent prostate cancers that are resistant to hormone therapy.   view more (2008-01-02)

Blocking protein kills prostate cancer cells, inhibits tumor growth, Jefferson scientists find
Researchers at Jefferson's Kimmel Cancer Center in Philadelphia have shown that they can effectively kill prostate cancer cells in both the laboratory and in experimental animal models by blocking a signaling protein that is key to the cancer's growth.   view more (2008-02-28)
Page 1 of 127 | 3170 Results
Previous0102030405060708091011   Next   
Sort By: Page Views | Date
© 2008 BrightSurf.com